Iron Fortified Beverages and Application in Women Predisposed to Anemia (FeDrink)

December 21, 2012 updated by: M Pilar Vaquero, National Research Council, Spain
  • The objective of the study is to know if consumption of an iron fortified fruit juice containing micronized iron pyrophosphate, is useful to increase iron status in women predisposed to iron deficiency anemia.
  • A secondary objective is to know if consumption of this iron fortified fruit juice modifies bone remodelling.

Study Overview

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women
  • non-smoker
  • non-pregnant
  • non-breastfeeding
  • serum ferritin <40 ng/ml
  • hemoglobin>=11g/dl

Exclusion Criteria:

  • Serum Ferritin >=40 ng/ml
  • Hemoglobin <11g/dl
  • Amenorrhea
  • Menopause
  • Iron deficiency anemia
  • Thalassemia
  • Hemochromatosis
  • Blood donors
  • Chronic gastric diseases
  • Renal diseases
  • Eating disorders
  • Allergy to any component of the study juices
  • Consumption of iron or ascorbic acid supplements within 4 month prior to participating in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo juices
Consumption of non-iron fortified fruit juices as part of the usual diet
Experimental: Iron fortified fruit juices
Consumption of iron fortified fruit juices as part of the usual diet
Consumption of micronized iron pyrophosphate supplemented fruit juices as part of the usual diet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Serum Ferritin
Time Frame: monitored during 16 weeks
monitored during 16 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Serum transferrin
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Hemoglobin
Time Frame: monitored during 16 weeks
monitored during 16 weeks
serum iron
Time Frame: monitored during 16 weeks
monitored during 16 weeks
transferrin saturation
Time Frame: monitored during 16 weeks
monitored during 16 weeks
soluble transferrin receptor
Time Frame: monitored during 16 weeks
monitored during 16 weeks
zinc protoporphyrin
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Total red blood cells
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Hematocrit
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Mean corpuscular volume
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Red blood cell distribution width
Time Frame: monitored during 16 weeks
monitored during 16 weeks
25-hydroxycholecalciferol
Time Frame: monitored during 16 weeks
monitored during 16 weeks
alkaline phosphatase bone-isoenzyme (ALP)
Time Frame: monitored during 16 weeks
monitored during 16 weeks
serum cross-linked N-telopeptide of type I collagen (NTx)
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Total cholesterol
Time Frame: monitored during 16 weeks
monitored during 16 weeks
HDL-cholesterol
Time Frame: monitored during 16 weeks
monitored during 16 weeks
LDL-cholesterol
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Glucose
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Serum triacylglycerols
Time Frame: monitored during 16 weeks
monitored during 16 weeks
T-chol/HDL-chol
Time Frame: monitored during 16 weeks
monitored during 16 weeks
LDL-chol/HDL-chol
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Systolic blood pressure
Time Frame: monitored during 16 weeks
monitored during 16 weeks
Diastolic blood pressure
Time Frame: monitored during 16 weeks
monitored during 16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2008

Primary Completion (Actual)

January 1, 2009

Study Completion (Actual)

May 1, 2009

Study Registration Dates

First Submitted

May 28, 2010

First Submitted That Met QC Criteria

June 2, 2010

First Posted (Estimate)

June 3, 2010

Study Record Updates

Last Update Posted (Estimate)

December 24, 2012

Last Update Submitted That Met QC Criteria

December 21, 2012

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iron-deficiency Anemia

Clinical Trials on non-fortified fruit juices consumed as part of the usual diet

Subscribe